Added to YB: 2026-07-15
Pitch date: 2026-07-13
PRTC.L [neutral]
PureTech Health plc
+0.64%
current return
Author Info
The Oak Bloke shares analysis of the UK stock market, particularly overlooked small caps. Sign up for the newsletter.
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
GBP 401.2M
Pitch Price
GBP 1.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.74
P/E
-3.58
EV/Sales
66.40
Sector
Biotechnology
Category
value
Oak Bloke Bonkers Conkers 12th July - $PRTC.L
PRTC.L (update): PureTech Health. Celea $150m financing efficient given Phase 3 single-drug, $202.5m valuation uplift (66%), $190m milestones + tiered royalties to 3%, 20% sub-license income. Smart money entering: Kevin Tang (activist, 5%), Briarwood Chase (SOTP value, 5%). Phase 3 IPF trial dosing began.
Read full article (3 min)